Midostaurin in Advanced Systemic Mastocytosis

被引：49

作者：

Chandesris, Marie-Olivia ^{[1
]}

Damaj, Gandhi ^{[2
]}

Canioni, Danielle ^{[3
]}

Brouzes, Chantal ^{[3
]}

Lhermitte, Ludovic ^{[3
]}

Hanssens, Katia ^{[4
]}

Frenzel, Laurent ^{[3
]}

Cherquaoui, Zoubair ^{[3
]}

Durieu, Isabelle ^{[5
]}

Durupt, Stephane ^{[5
]}

Gyan, Emmanuel ^{[6
]}

Beyne-Rauzy, Odille ^{[7
]}

Launay, David ^{[8
]}

Faure, Cyril ^{[9
]}

Hamidou, Mohamed ^{[10
]}

Besnard, Sophie ^{[11
]}

Diouf, Momar ^{[12
]}

Schiffmann, Aurelie ^{[13
]}

Niault, Mathilde ^{[14
]}

Jeandel, Pierre-Yves ^{[15
]}

Ranta, Dana ^{[16
]}

Gressin, Remi ^{[17
]}

Chantepie, Sylvain ^{[2
]}

Barete, Stephane ^{[18
]}

Dubreuil, Patrice ^{[4
]}

Bourget, Philippe ^{[3
]}

Lortholary, Olivier ^{[3
]}

Hermine, Olivier ^{[19
]}

机构：

[1] French Natl Reference Ctr Mastocytosis CERE MAST, Paris, France

[2] Univ Lower Normandy, Sch Med, Caen, France

[3] Necker Univ Hosp, Paris, France

[4] Paoli Calmettes Inst, Marseille, France

[5] Lyon Sud Univ Hosp, Lyon, France

[6] Tours Univ Hosp, Tours, France

[7] Purpan Univ Hosp, Toulouse, France

[8] Lille Univ Hosp, Lille, France

[9] Vesoul Reg Univ Hosp, Vesoul, France

[10] Hotel Dieu Univ Hosp, Nantes, France

[11] Rennes Univ Hosp, Rennes, France

[12] Amiens Univ Hosp, Amiens, France

[13] St Eloi Univ Hosp, Montpellier, France

[14] Bretagne Sud Reg Hosp, Lorient, France

[15] Archet 1 Univ Hosp, Nice, France

[16] Nancy Univ Hosp, Nancy, France

[17] Grenoble Univ Hosp, Grenoble, France

[18] Tenon Univ Hosp, Paris, France

[19] Imagine Inst, Paris, France

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 26期

关键词：

D O I：

10.1056/NEJMc1515403

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2605 / 2607

页数：3

共 50 条

[1] Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Gotlib, Jason
Kluin-Nelemans, Hanneke C.
George, Tracy I.
Akin, Cem
Sotlar, Karl
Hermine, Olivier
Awan, Farrukh T.
Hexner, Elizabeth
Mauro, Michael J.
Sternberg, David W.
Villeneuve, Matthieu
Labed, Alice Huntsman
Stanek, Eric J.
Hartmann, Karin
Horny, Hans-Peter
Valent, Peter
Reiter, Andreas
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (26): : 2530 - 2541
[2] Efficacy of Midostaurin and Cladribine in advanced systemic mastocytosis
Lubke, J.
Jawhar, M.
Naumann, N.
Horny, H. P.
Weiss, C.
Metzgeroth, G.
Kreil, S.
Cross, N. C. P.
Sotlar, K.
Fabarius, A.
Hofmann, W. K.
Valent, P.
Gotlib, J.
Reiter, A.
Schwaab, J.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 59 - 60
[3] FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis
Kasamon, Yvette L.
Ko, Chia-Wen
Subramaniam, Sriram
Ma, Lian
Yang, Yuching
Nie, Lei
Shord, Stacy
Przepiorka, Donna
Farrell, Ann T.
McKee, Amy E.
Pazdur, Richard
ONCOLOGIST, 2018, 23 (12): : 1511 - 1519
[4] Midostaurin in advanced systemic mastocytosis: A systematic review and metaanalysis.
Abuhelwa, Ziad
Beran, Azizullah
Kahlon, Navkirat
Sayeh, Wasef
Khokher, Waleed
Assaly, Ragheb
Hamouda, Danae M.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[5] Comprehensive Cytokine Profiling of Patients with Advanced Systemic Mastocytosis Treated with Midostaurin
Ediriwickrema, Asiri
DeAngelo, Daniel J.
George, Tracy I.
Rosenberg-Hasson, Yael
Perkins, Cecelia
Langford, Cheryl
Gotlib, Jason R.
BLOOD, 2018, 132
[6] Midostaurin in Advanced Systemic Mastocytosis: A Systematic Review and Meta-analysis
Abuhelwa, Ziad
Beran, Azizullah
Kahlon, Navkirat
Sayeh, Wasef
Khokher, Waleed
Assaly, Ragheb
Hamouda, Danae M.
AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (06) : E574 - E576
[7] Predicting the Clinical Course of Treatment with Midostaurin in Patients with Advanced Systemic Mastocytosis
Luebke, Johannes
Naumann, Nicole
Brand, Timo
Horny, Hans-Peter
Rudelius, Martina
Sotlar, Karl
Metzgeroth, Georgia
Fabarius, Alice
Hofmann, Wolf-Karsten
Schwaab, Juliana
Reiter, Andreas
BLOOD, 2023, 142
[8] Treatment of systemic mastocytosis in an infant with midostaurin
Liu, Mona M.
Kohn, Lisa A.
Roach, Gavin D.
Sun, Grace
Garcia-Lloret, Maria I.
Butte, Manish J.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (08): : 2929 - +
[9] Indirect treatment comparisons of avapritinib versus midostaurin for patients with advanced systemic mastocytosis
Pilkington, Hollie
Smith, Sarah
Roskell, Neil
Iannazzo, Sergio
FUTURE ONCOLOGY, 2022, 18 (13) : 1583 - 1594
[10] Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin
Gotlib, Jason
Kluin-Nelemans, Hanneke C.
Akin, Cem
Hartmann, Karin
Valent, Peter
Reiter, Andreas
EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 487 - 498

← 1 2 3 4 5 →